Clinical Trial Update: Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 study of pembrolizumab, vorinostat, and temozolomide in newly diagnosed glioblastoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Temozolomide (Temozolomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Glioblastoma, Brain Tumor | Phase 1 | Status: COMPLETED | Results posted: 2025-10-06